Pacira Biosciences, Inc. is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company relocated its R&D and pilot-scale manufacturing functions to an existing building at 10410 Science Center Drive. Having designed the original shell and several renovations over… Read more »
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company focused on the discovery and development of safe and effective immunotherapies for oncology and autoimmune/inflammation diseases. The company’s acquisition of several companies drove the need to expand its facilities and bring these acquisitions under one roof in a leased 75,000-square-foot building. The project included renovation of… Read more »
Project SHORE (Shire Operations for Regenerative Expansion) was master planned to be a new build-to-suit campus for Shire’s Regenerative Medicine Business Unit and provide increased commercial production capacity of Dermagraft, a dermal substitute approved for treatment of diabetic foot ulcers, along with future capacity for other products. The master plan includes an ultimate build out… Read more »
Gilead Sciences commissioned this project to further its commitment to advancing therapeutics in the quest to improve lives. With over 23 acres in an industrial and manufacturing park in Southern California, Phase 1 is designed for 320,000 usable square feet in five buildings with generous vertical clearances to accommodate manufacturing equipment. The complete campus build-out… Read more »
The La Jolla Institute for Allergy and Immunology is a private biomedical research institute located in UC San Diego’s Science Research Park. The South Shell Lab Build-Out project consists of 6,000 square feet of flexible laboratory space for biomedical research, including a tissue culture lab, principal investigator offices and a lab technician office area. The project… Read more »
This campus houses one of the most advanced facilities of its type in the world, setting new standards not only for biotech process design and automation but also in project execution and delivery. Since its completion, this 90,000-liter-capacity facility has produced significant cancer and arthritis therapies for the U.S. and the world. While all mammalian… Read more »